The benzodiazepine-like natural product tilivalline is produced by the entomopathogenic bacterium Xenorhabdus eapokensis

Hendrik Wolff; Helge B. Bode

doi:10.1371/journal.pone.0194297

Abstract

The pyrrolobenzodiazepine tilivalline (1) was originally identified in the human gut pathobiont Klebsiella oxytoca, the causative agent of antibiotic-associated hemorrhagic colitis. Here we show the identification of tilivalline and analogs thereof in the entomopathogenic bacterium Xenorhabdus eapokensis as well as the identification of its biosynthesis gene cluster encoding a bimodular non-ribosomal peptide synthetase. Heterologous expression of both genes in E. coli resulted in the production of 1 and from mutasynthesis and precursor directed biosynthesis 11 new tilivalline analogs were identified in X. eapokensis. These results allowed the prediction of the tilivalline biosynthesis being similar to that in K. oxytoca.

Citation: Wolff H, Bode HB (2018) The benzodiazepine-like natural product tilivalline is produced by the entomopathogenic bacterium Xenorhabdus eapokensis. PLoS ONE 13(3): e0194297. https://doi.org/10.1371/journal.pone.0194297

Editor: Willem J.H. van Berkel, Wageningen Universiteit, NETHERLANDS

Received: December 18, 2017; Accepted: February 28, 2018; Published: March 29, 2018

Copyright: © 2018 Wolff, Bode. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: Data is available from MassIVE (https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp) under ID number MSV000081778.

Funding: This work was supported by a Starting grant from the European Research Council (grant agreement number 311477) and Deutsche Forschungsgemeinschaft INST 161/810-1 to Dr. Helge B. Bode. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Entomopathogenic gammaproteobacteria of the genus Xenorhabdus live in symbiosis with nematodes of the genus Steinernema. Soil living infective juvenile nematodes are carrying Xenorhabdus, hunting and killing insect larvae as food source and reproductive space [1–3]. To maintain this specific lifestyle (bypass of the insect immune system, killing and lysis of the insect, defending the insect corpse from microorganisms and other food competitors) Xenorhabdus produce a wide variety of natural products [4–7]. If insect cadaver depletion occurs, a new generation of juvenile nematodes and bacteria re-associate and emerge from the cadaver in search of a new insect prey [2].

Most natural products (NPs) of Xenorhabdus are produced by non-ribosomal peptide synthetases (NRPSs), polyketide synthases or hybrids thereof. The NRPS module architecture can often be identified using in silico methods such as antiSMASH [8] that predicts enzyme domain function and also shows the biosynthetic gene cluster (BGC) similarity to other BGCs with known natural products. In NRPS-based biosynthesis several catalytically active domains can be grouped into modules that are responsible for the activation and processing of the individual building blocks usually amino acids. The adenylation (A) domain specifically selects an amino acid substrate and activates it in an ATP dependent manner to attach it covalently to the downstream thiolation or peptidyl carrier protein domain (T). The condensation (C) domain joins adjacent T domain bound amino acids and a growing peptide chain is transferred downstream. A NRPS starting module typically consists only of an A domain and a T domain whereas the final termination module often includes a thioesterase (TE) or a reductase (Re) domain to release the peptide from the NRPS enzyme complex [9].

Besides accelerating developments in genome analysis, recent developments in ultra-performance liquid chromatography (UPLC) coupled to high resolution mass spectrometry (HR-MS) have allowed high-throughput chemical analysis of microbial cultivation samples. Subsequent data mining techniques like network analyses [10] are used to extract bacterial NP profiles which in turn can be integrated in genome mining approaches to achieve a broad NP producer characterization and help to identify new compounds [11].

Pyrrolobenzodiazepines (PBDs) are a class of natural products known for their sequence specific DNA binding ability, which causes cytotoxicity [12]. Bacteria occupying different ecological niches are reported to produce PBDs [13]. For example, terrestrial actinobacteria such as Streptosporangium sibiricum, Streptomyces refuineus sbsp. thermotolerans or Streptomyces achromogenes produce sibiromycin [14,15], anthramycin [16–18] and tomaymycin [19–21], respectively. The PBD tilivalline (TV, 1), is produced by Klebsiella oxytoca [22–24], a human gut pathobiont [25,26]. Klebsiella oxytoca shifts from an anti-inflammatory commensal to a pro-inflammatory pathobiont during antibiotic treatment [27,28]. When antibiotic driven enterobacterial overgrowth occurs and 1 is produced in higher amounts by Klebsiella oxytoca, activation of mucosal immune cells leads to a damage of the intestinal epithelium [24,27]. This in turn increases intestinal permeability and chronic activation of the immune system resulting the pathology of antibiotic associated hemorrhagic colitis (AAHC) [28–31].

Here, the identification of the TV BGC in several entomopathogenic Xenorhabdus strains and production of 1 by X. eapokensis strain DL20 [32] was shown under laboratory conditions, as previously described briefly [33]. Additionally, a precursor directed biosynthesis approach led to increased production of TV and analogs thereof. Furthermore, heterologous expression of the TV BGC of X. indica in E. coli resulted in TV production and a mutasynthesis approach resulted in production of several TV analogs highlighting the enzyme promiscuity.

Results

Tilivalline gene cluster analysis

Genomic mining of 26 Xenorhabdus genomes (S1 Table) using antiSMASH 3.0 [8] revealed the presence of a BGC encoding a NRPS in X. indica, X. eapokensis strain DL20, X. hominickii DSM17908 and strain ANU1, X. kozodoi, X. cabanillasii, X. nematophila F1 and X. beddingii with an average amino acid identity >50% to the TV NRPS of Klebsiella oxytoca [28] (Fig 1, S2 Table). In K. oxytoca the TV BGC consists of five genes described as the aroX operon and three genes (6.4 kbp in total size) encoding the A domain NpsA, the T domain ThdA and the NRPS modul NpsB (consisting of a C, an A, a T and a Re domain) [28]. Notably, NpsA and ThdA are freestanding domains in K. oxytoca and X. beddingii (Fig 1). In all other Xenorhabdus genomes the NRPS is encoded on two genes, hereafter named xtvAB (from Xenorhabdus tilivalline) where in contrast to Klebsiella and X. beddingii xtvA encodes a A-T di-domain as starting module.

Download:

Fig 1. Tilivallin (1) biosynthetic gene cluster (BGC) composition in (A) Klebsiella oxytoca sp. and Xenorhabdus beddingii and (B) additional Xenorhabdus strains.

The TV BGC contains the aroX operon and encodes a bimodular NRPS (grey arrows; in Klebsiella sp. NpsAB and ThdA, in Xenorhabdus sp. XtvAB) with corresponding domain architecture annotation according to antiSMASH analysis and [28]). Note the differences in NRPS architecture in (A, freestanding) and (B, fused A-T didomain). Abbreviations: A (adenylation), T (thiolation), C (condensation), Re (reductase) domain. Colored arrows show genes of the aroX operon encoding the following enzymes: Orange (HmoX, 4-hydroxyphenyl acetate-3-monoxygenase), violet (AdsX, 2-amino-2-deoxy-isochorismate synthase), red (IcmX or PhzD homolog, respectively, isochorismatase), blue (DhbX, 2,3-dihydro-dehydrogenase), green (AroX, 2-keto-3-deoxy-D-arabinoheptulosonate phosphate synthase), white (2,3-dihydroxybenzoate-AMP ligase of chrysobactin BGC). Arrows with shaded colors and asterisk indicate that corresponding genes are not encoded in TV BGC but elsewhere in the genome.

https://doi.org/10.1371/journal.pone.0194297.g001

The aroX operon of K. oxytoca contains five genes (hmoX, adsX, icmX, dhbX, aroX) coding for enzymes which are thought to be responsible for synthesis of the TV precursor 3-hydroxy anthranilic acid [28,34] (Fig 1, S2 Table). In general, none of the analyzed Xenorhabdus sp. genomes harbor the full aroX operon as described for K. oxytoca because the anthranilate-3-monoxygenase HmoX homolog is not encoded in the TV BGC but elsewhere on the genome. X. eapokensis strain DL20, X. nematophila F1, and X. hominickii spp. encode several aroX operon genes as part of the TV BGC but X. beddingii is lacking aroX (encoding 2-keto-3-deoxy-D-arabinoheptulosonate phosphate synthase) and X. kozodoi encodes the 2-amino-4-deoxychorismate synthase AdsX somewhere else in the genome. Interestingly, X. indica encodes AdsX, the IcmX homolog PhzD and the 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase DhbX not as part of the TV BGC, but as part of a predicted chrysobactin siderophore BGC [35]. Finally, X. cabanillasii is lacking the aforementioned four aroX operon genes and no homologs could be identified in the referred genomic data (Fig 1, S2 Table).

Production of tilivalline and natural analogs in X. eapokensis

In order to investigate the tilivalline production, six Xenorhabdus strains harboring the TV BGC were chosen for cultivation and mass spectrometric analysis. The strains were grown in either LB broth, SF-900 or Schneider′s insect medium including Amberlite XAD-16, which was harvested after three days of incubation and extracted with butanol. Subsequently, these extracts were analyzed using UPLC-HR-MS/MS, to test whether 1 is produced under laboratory conditions (S1 Table).

Only the X. eapokensis extract exhibited a molecular feature of m/z 334.1550 [M+H]⁺ (Fig 2, S1 Fig) with a predicted sum formula of C₂₀H₁₉N₃O₂ (Table 1) characteristic for TV (1) [23]. A subsequent analysis of the MS fragmentation data of this molecular feature to reference data of 1 produced by K. oxytoca [29] and a synthetic TV standard (S1 Fig) provided additional evidence that the molecule is indeed 1 produced by X. eapokensis. Quantification showed that 1 is produced in a range of in 0.032 mg/L in LB broth, 0.41 mg/L in Schneider′s insect medium and 2.06 mg/L in SF-900 insect medium.

Download:

Fig 2. UPLC-HRMS/MS analysis of crude extracts of X. eapokensis grown in SF-900 medium.

(A) Extracted ion chromatograms (EIC) of natural produced TV (1), and derivatives thereof (2–5) with structures according to (C). (B) EICs of 1 and derivatives thereof (2, 6–8, 10–15) with structures according to (D) of precursor directed feeding experiment (details see text). Note: 1* shows TV signal intensity in an extract without supplementation of 3-hydroxy anthranilic acid.

https://doi.org/10.1371/journal.pone.0194297.g002

Download:

Table 1. Overview of TV, derivatives thereof and putative biosynthetic precursors described in this work.

https://doi.org/10.1371/journal.pone.0194297.t001

A subsequent MS/MS analysis on X. eapokensis extraction samples using the GNPS network analysis tool [10] revealed a subnetwork containing TV related compounds (2–5), (Figs 2 and 3, Table 1) which were subjected to a detailed MS/MS analysis. This allowed the identification of the molecular feature of m/z 318.1597 [M+H]⁺ (2) as 9- deoxy-TV due to a mass shift of 15.9 Da in the network analysis. Compared to 1 this indicates that the hydroxyl group is missing (Fig 4a) as was also described previously from K. oxytoca [36]. Its typical MS/MS characteristics (Fig 4a) are two fragment ions namely m/z 201.1028 [M+H]⁺ that show a higher signal intensity than an expected second isotopic signal of ubiquitous PBD fragment ion m/z 199.1227 [M+H]⁺ would cause, and m/z 120.0444 [M+H]⁺, the PBD A-ring fragment without substitutions. Next, the molecular feature of m/z 350.1497 [M+H]⁺ (3) shows the same 15.9 Da parent mass difference in network analysis as 2 but now as additional mass compared to 1 (Fig 3). Its MS/MS analysis (Fig 4b) shows a characteristic double loss of 18 Da from m/z 350.1497 [M+H]⁺ parent ion, most likely attributable to neutral losses of two hydroxyl groups as PBD A-ring substituents. This is also reflected in the occurrence of fragment ions m/z 233.0918 [M+H]⁺ and A-ring fragment m/z 152.0341 [M+H]⁺, both 15.9 Da larger than the mono hydroxyl substituted fragment ion counterparts m/z 217.0972 [M+H]⁺ and m/z 136.0385 [M+H]⁺ of 1. Based on these observations, 3 is determined as dihydroxy TV. In accordance to TV structure data [28], biosynthesis proposals [24,34,36], and precursor directed feeding experiments (see Results below) one A-ring hydroxyl group might be located at position 9 part of the PBD A-ring (Fig 2). The exact position of the second hydroxyl group remains elusive but might be at position 7 or 8 as different potential anthranilate hydroxylases are encoded in the X. eapokensis genome (see Discussion) (S2 Table). Finally, molecular features of m/z 332.1411 [M+H]⁺ (4) (S2a Fig) and m/z 348.1337 [M+H]⁺ (5) (S2b Fig) are characterized as dehydro analogs of 1 and 3 by the mass shift of 1.9 Da of 4 to 1 and 3 to 5, respectively, as shown in the network analysis (Fig 3). Albeit a distinct assignment of the double bound position is not achievable with the applied methods, characteristic A-ring MS/MS fragment masses m/z 197.1073 [M+H]⁺ and m/z 215.0811 [M+H]⁺ of 4 and m/z 330.1234 [M+H]⁺ of 5, indicate desaturation in the PBD C-ring (S2 Fig). In summary, X. eapokensis strain DL20 cultivated under laboratory conditions produces TV (1) and four derivatives thereof: 9-deoxy-TV (2) and the three hitherto undescribed analogs dihydroxy TV (3), dehydro TV (4) and dehydro-dihydroxy TV (5) (Table 1).

Download:

Fig 3. TV specific subnetwork analysis of a X. eapokensis cultivation in SF-900 insect medium.

Nodes (circles) are labeled with precursor ion masses [M+H]⁺ of TV (1) and derivatives thereof (2–5). Precursor mass differences are depicted on connecting edges (grey lines).

https://doi.org/10.1371/journal.pone.0194297.g003

Download:

Fig 4. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in SF-900 medium.

(A) MS/MS spectrum of 9-deoxy-TV (2). (B) MS/MS spectrum of dihydroxy-TV (3). Signals are annotated with predicted sum formulas, detection errors and putative molecule fragment structures. Red diamonds indicate precursor ions.

https://doi.org/10.1371/journal.pone.0194297.g004

Furthermore, two ions were detected in X. eapokensis cultivation extract that correlate to the first NRPS derived intermediate named tilimycin or kleboxymycin (16) [24,34,36] and its keto analog 17, respectively (Table 1, S4 Fig). Both are lacking the characteristic indole substituent at the C11 position, instead harboring a hydroxyl group (16, carbinolamine precursor), or a keto group (17, keto precursor). Mass spectra of 16 (S4 Fig) are in accordance with published data of Tse et al. [34] indicating that not all NRPS-produced intermediates are directly converted to 1 via indole addition.

X. eapokensis precursor directed biosynthesis and enhanced TV production

A precursor directed biosynthesis approach tested the capability of X. eapokensis to generate TV and non-natural analogs thereof by supplementing the SF-900 culture broth with different substituted 2-amino benzoic acids (ABA), indoles or prolines (S3 Table), similar to precursor directed biosynthesis approaches described for sibiromycin [37] or tomaymycin [21]. Cultivation extracts were analyzed by UPLC-HRMS/MS (Fig 2). First, comparison of TV production in pure SF-900 medium to SF-900 medium supplemented with either 1 mM 3-hydroxy anthranilic acid (3-HAA), 0.1 mM or 1 mM indole revealed an increase in TV production from 2.06 mg/L in the wildtype to 2.9 mg/L, 3.6 mg/L, and 6.2 mg/L TV, respectively. The largest amount of 1 (6.4 mg/L) was obtained from supplementation with 1 mM indole and 1 mM 3-HAA.

Second, cultures were supplemented with different ABAs, indole or proline derivatives (S3 Table) and extracts were subjected to detailed MS/MS fragmentation analysis. This revealed production of several non-natural TV analogs with different substitutions in the A-ring (6–8, 10) and C-ring (11) of the PDB, or variations of the indole moiety (12–15) (S3 Fig, S3 Table). The first set of added precursors tested the X. eapokensis XtvA A domain substrate flexibility regarding acceptance of halogenated, methylated or methoxylated aminobenzoic acid (ABA) derivatives (S3 Table). The results (Fig 2) suggest a preference of ABAs substituted at the 3-position. Qualitatively, highest product signals are observed for 3-HAA supplementation resulting in 1 followed by preferences of 3-methoxy ABA, 3-methyl ABA, 3-chloro ABA and 5-chloro ABA, resulting in TV analogs 10, 8, 6, 7, respectively (Fig 2b). Notably, none of the expected TV derivatives were observed in X. eapokensis after supplementation with 5-methyl ABA or 5-methoxy ABA but production of 1 was as high as in SF-900 medium without supplementation (data not shown). This indicates a substrate preference of XtvA. In a similar manner, the XtvB A domain substrate flexibility was tested by supplementation of different proline analogs, namely 3-methyl, 3-benzyl, and 4-hydroxy proline and pipecolic acid but only incorporation of 3-methyl proline was observed, resulting in TV analog 11 (Fig 2b, S3 Fig). Finally, indole derivatives with substitution at position 5 (5-fluoro-, 5-phenyl-, 5-methyl) and 7-azaindole were incorporated successfully, resulting in TV analogs 12–15 (Fig 2b, S3 Fig). In summary, X. eapokensis produces high amounts of 1 in the presence of high concentrations of 3-HAA acid and indole. If the bacteria are additionally supplied with ABA derivatives substituted in the 3-position or with indole derivatives, the expected TV analogs can be obtained in several cases.

Heterologous expression of XtvAB from X. indica

According to Xenorhabdus genome analysis (Fig 1), X. eapokensis strain DL20 not only encodes the NRPS of the TV BGC but also four genes of the aroX operon, encoding genes for TV precursor biosynthesis (S2 Table). Additionally, the production of 1–5 in the wildtype strain suggested the presence of different anthranilic acid precursors in the producer. In contrast, cultivation of X. indica did not show production of 1 or derivatives thereof. Genetic analysis revealed the presence of the TV NRPS in X. indica but absence of the aroX operon in proximity to the TV NRPS as shown for K. oxytoca [28] and some Xenorhabdus strains (Fig 1). This raised the question whether the X. indica TV NRPS is in principle functional, if sufficient supply of TV biosynthetic precursors is available. To test the biosynthetic capacity of X. indica, the corresponding NRPS (XtvAB, both proteins show 73% pairwise amino acid identity to the X. eapokensis homolog) encoding genes were heterologously expressed in E. coli.

E. coli TV production and mutasynthesis

Cultivation of E. coli DH10B entD::mtaA including the arabinose inducible tilivalline production vector in LB media supplemented with 3-HAA led to a TV production in the range of 0.016 mg/L in LB broth (Fig 5) thus xtvAB of X. indica is indeed functional but production rate is much lower compared to the X. eapokensis wildtype (Fig 2). If arabinose was lacking (Fig 5C1) or no 3-HAA was added (Fig 5C2), no production of 1 was observed. Mutasynthesis experiments as performed in X. eapokensis (S3 Table) led to the production of TV analogs 2, 6–10 and 12–14 as confirmed by MS/MS analysis (S3 Fig). Similar to the X. eapokensis experiment 5-methoxy ABA was also not accepted as substrate. In contrast, the TV analog 9 (from incorporation of 5-methyl ABA) was observed but not TV analog 11 and 15. However, these results in general show the use of E. coli as expression host as another possibility to obtain TV analogs.

Download:

Fig 5. UPLC-HRMS/MS analysis of a crude extract of induced E. coli DH10B entD::mtaA carrying pHW10 (containing xtvAB from X. indica) grown in LB medium supplemented with different ABAs according to S3 Table.

(A) Extracted ion chromatograms of TV (1), 9-deoxy TV (2) and TV analogs (6–10 and 12–14) with substitution patterns listed in (B). Identified ions and predicted sum formulas are listed in (Table 1), MS/MS data is shown in (Fig 4 and S3 Fig). Control C1 (non-induced E. coli DH10B entD::mtaA pHW10 with 1 mM 3-hydroxy anthranilic acid) and C2 (induced E. coli DH10B entD::mtaA pHW10 without supplementation).

https://doi.org/10.1371/journal.pone.0194297.g005

Discussion

Following the first observation of tilivalline (1) production in entomopathogenic Xenorhabdus bacteria [33], this study examines in detail the production of TV and analogs thereof using UPLC-MS/MS techniques in combination with in silico genome mining strategies.

X. eapokensis and seven more Xenorhabdus strains harbor the TV BGC with similarities to the TV BGC described for the human gut pathobiont K. oxytoca [28]. Following in silico analyses, two different TV BGC architectures were found. Both contain a bimodular NRPS, similar to BGCs of structural pyrrolobenzodiazepine relatives anthramycin [16–18], sibiromycin [14,15] and tomaymycin [19–21,38]. Furthermore the TV BGC includes the aroX operon, harboring several genes important for TV precursor synthesis as proposed in a TV biosynthesis pathway for K. oxytoca [34,36].

Following these proposals and genetic analyses this study elucidates the biosynthesis pathway for Xenorhabdus (Fig 6). Production of 2 is most likely explained by XtvA incorporation of anthranilic acid, a conversion product of chorismate by the anthranilate synthase homolog TrpE, originally being part of the tryptophan biosynthesis (S2 Table). An alternative anthranilate production pathway due to tryptophan catabolism via kynurenine seems unlikely, due to the lack of the key enzymes KynABU not encoded in Xenorhabdus genomes (data not shown). Chorismate in turn is a main product of the shikimic acid pathway. Homologs of all shikimic acid pathway enzymes are present in X. eapokensis with amino acid sequence identities >50% to referred query sequences (S2 Table). Presence of 1 with its typical hydroxylation at position 9 requires 3-HAA as XtvA substrate [28,34]. In general, there are two possible pathways to 3-HAA: First, action of AdsX, PhzD (or the Klebsiella homolog IcmX, respectively) and DhbX. All three enzymes are encoded in the aroX operon in Klebsiella and X. eapokensis (amino acid sequence similarities >48%) (Fig 1, S2 Table). The 2-amino-2-deoxy-isochorismate synthase AdsX converts chorismate to 2-amino-4-deoxy isochorismate (ADIC), while the ADIC hydrolase PhzD and the DHHA dehydrogenase DhbX in turn hydrolyze and dehydrate ADIC to 6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylate (DHHA) and finally to 3-HAA (Fig 6). Previous work [36] has demonstrated that Klebsiella oxytoca AHC-6 ΔadsX, ΔicmX and ΔdhbX deletion mutants are all impaired in TV production. Contrary, in K. oxytoca strain MH43-1 mutants in the icmX homolog phzD were still producing 1 [34]. Another proposed pathway to 3-HAA is via the anthranilate-3-monooxygenase HmoX but deletion of the corresponding gene in K. oxytoca MH43-1 and AHC-6 did not impair the production of 1 [34,36].

Download:

Fig 6. Proposed tilivallin (1) biosynthesis of X. eapokensis.

Chorismate is a main product of the shikimic acid pathway modified by various enzymes to precursors accepted by XtvA. NRPS enzymes XtvA and XtvB activate anthranilic acid or proline (and analogs thereof), respectively, due to ATP hydrolysis and bind resulting aminoacyl adenylates to corresponding thiolation domains (T). After condensation domain (C) mediated reaction of the T domain bound aminoacyls, resulting dipeptide undergoes a reductive cyclisation by action of the terminal reduction domain (Re) release mechanism resulting a pyrrolobenzodiazepine core structure (16, 17). Finally post NRPS, free indole (or derivatives thereof) is added non enzymatically, resulting in the production of 1. Compound abbreviations: ADIC = 2-amino-4-deoxy isochorismate, DHHA = 6-amino-5-hydroxycyclohexa-1,3-diene-1-carboxylate, 3-HAA = 3-hydroxyanthranilic acid, 5-HAA = 5-hydroxyanthranilic acid, 3,5-DHAA = 3,5-dihydroxyanthranilic acid, 4,5-DHAA = 4,5-dihydroxyanthranilic acid. Enzyme abbreviations: AdsX = ADIC synthase, PhzD = ADIC hydrolase, DhbX = DHHA dehydrogenase, TomO = salicylyl-coenzyme A 5-hydroxylase (anthranlilic acid oxygenase), TomEF = phenol-2-monooxygenase reductase/oxygenase, XtvAB = TV NRPS module 1 and 2.

https://doi.org/10.1371/journal.pone.0194297.g006

Furthermore, presence of 3 and 5 suggest a dihydroxylated ABA as additional XtvA substrate. Enzymatic conversion from anthranilic acid to 4,5-dihydroxy anthranilic acid (4,5-DHAA) is described in tomaymycin synthesis [21,38] by the salicylyl-CoA-5-hydroxylase TomO and the phenol-2-monooxygenase reductase/oxygenase TomEF (Fig 6) but resulting 3 and 5 would lack the expected 9-hydroxylation. So, it is proposed that 3-HAA serves as an alternative substrate for TomO mediated 5-hydroxylation, resulting in 3,5-dihydroxy anthranilic acid (3,5-DHAA) but the pathway leading to its production has not been fully elucidated yet. Interestingly, occurrence of TV derivatives 4 and 5 suggest a desaturation of the PBD C-ring (S2 Fig) that could either occur prior or after NRPS catalyzed incorporation. Characterized proline dehydrogenases PutA [39] and DpdH [40], both involved in proline degradation to glutamate, produce 1-pyrroline-5-carboxylic acid and 1-pyrroline-2-carboxylic acid, respectively. Additionally, LhpD, a cis-3-hydroxy-L-proline dehydratase [41] is proposed to produce 1-pyrroline-2-carboxylic acid. However, both mentioned pyrroline carboxylic acids are unlikely the XtvB substrate for C domain catalyzed reaction with XtvA because T domain attached 1-pyrroline-5-carboxylic acid or 1-pyrroline-2-carboxylic acid do not provide a free nitrogen atom, required for the C domain mediated nucleophilic attack to form a peptide bond. Another possibility are NRPS in trans tailoring enzymes as shown for Oxy proteins in teicoplanin biosynthesis [42].

Phylogenetic studies on the TV NRPS of K. oxytoca (NpsAB) addressing A domain substrate adenylation specificity suggest, that NpsA accepts anthranilic acid derivatives and NpsB pyrrole containing molecules, forming the TV precursor [24,28]. This is in line with our experimental results of a precursor directed biosynthesis approach of X. eapokensis (Fig 2) and mutasynthesis studies of an XtvAB expressing E. coli strain (Fig 5), where TV is only built in the presence of supplemented 3-hydroxy anthranilic acid.

During NRPS reaction, both T domain bound aminoacyls are fused by the C domain and subsequent action of the terminal reductase domain releases a dipeptidyl aldehyde that undergoes intramolecular cyclization, resulting the PBD imine/carbinolamine intermediates 16 and 17, latter one described as tilimycin/kleboxymycin (Table 1) [24,34,36]. Finally, 1 results from indole attacking non-enzymatically at the C11 position [24,34].

XtvAB expressing E. coli or wildtype X. eapokensis could serve as a starting point for biotechnologically produced PBDs with varying substitution in PBD A-ring, as demonstrated for tomaymycin [21] and sibiromycin [37,43]. Furthermore, enzyme catalyzed PBD synthesis is stereoselective and avoids the use of toxic chemicals in contrast to chemical PBD synthesis [44]. Substituted PBDs for their part, can serve as monomeric [45] or dimeric [46] building blocks for antibody payloads in antineoplastic chemotherapeutics due to their cytotoxic properties. For instance, anthramycin shows sequence selective DNA minor groove binding and its active imine builds an aminal linkage to guanine DNA bases [47] thereby disturbing protein-DNA interactions. Albeit TVs exact mode of action is unknown, gut epithelial cells are affected by TV in vitro [28]. Additionally, it has been demonstrated that tilimycin (16) exhibit a greater cytotoxicity than tilivalline (1) on epithelial Hep-2 cells [34].

Based on this bioactivity data it can be speculated that TV derivatives are also beneficial for Xenorhabdus in its symbiotic lifestyle. Xenorhabdus live in symbiosis with Steinernema nematodes, hunting and killing insect larvae as food source and reproductive space [1–3]. This specific lifestyle accommodates various difficulties e.g. bypassing the insect immune system, insect killing and lysis as well protecting of the insect corpse against food competitors like other soil-living microorganisms. To cope that challenges, Xenorhabdus produce a wide variety of natural products [5–7,48].

However, a crucial step before reproduction in the insect corpse is the infection of the prey insect. Nematodes carrying the entomopathogenic bacteria penetrate the insect through natural openings such as the mouth, anus or spiracles [49]. Having entered the insect, the nematode regurgitates the bacteria [50]. To enter deeper tissue layers or infect the insect hemocoel, the bacteria must overcome epithelial cell layers that form a barrier between tissue and environment. Hitherto no natural compounds are reported to facilitate this step of nematode/bacteria insect prey colonization so cytotoxic TV (1) and tilimycin (16) could play a key role in this early step of Xenorhabdus/Steinernema reproductive life cycle. Therefore, future work will address the biochemical identification of Xenorhabdus produced PBDs cell target(s) in an ecological context to provide new insights in bacterial nematode symbiosis system.

Material and methods

Identification of the TV BGC in Xenorhabdus

The TV producing BGC was identified using antiSMASH v3.0 [8] analyses of genomes described in (Table 1). Protein similarity calculations were performed using Geneious v6.0 and the clustalW pairwise alignment algorithm. Homologous gene search was done using algorithms of the online BLAST tool or a custom Geneious v6.0 BLAST search.

Cultivation of microorganisms

All E. coli and Xenorhabdus strains were grown in liquid or on solid LB-medium (pH 7.5, 10 g/L tryptone, 5 g/L yeast extract and 10 g/L NaCl), SF-900 II SFM (Thermo Fisher Scientific) or Schneider′s Insect Medium (Sigma Aldrich). Solid media contained 1.5% (w/v) agar. S. cerevisiae strain CEN.PK 113-7D and derivatives were grown in liquid or solid YPD-medium (10 g/L yeast extract, 20 g/L peptone and 20 g/L glucose). Agar plates contained 2% (w/v) agar. Kanamycin (20 μg/mL) and G418 (200 μg/mL) were used as selection markers. All strains were cultivated at 30°C.

Molecular biological methods

Genomic DNA of selected Xenorhabdus strains was isolated using the Qiagen Gentra Puregene Yeast/Bact Kit. Polymerase chain reaction (PCR) was performed with oligonucleotides obtained from Eurofins Genomics. All PCR reactions were performed using Phusion Hot Start II High-Fidelity DNA polymerase (Thermo Scientific) according to the manufacturers’ instructions. DNA purification was performed using MSB Spin PCRapace Kit (Stratec Biomedical) according to the manufacturers’ instructions. Plasmid isolation from E. coli was performed using Invisorb Spin Plasmid Mini Two Kit (Stratec Biomedical) according to the manufacturers’ instructions. Transformation of yeast cells was done according to an established protocol [51]. Successfully constructed plasmids were isolated from yeast transformants and subsequent E. coli DH10B entD::mtaA was transformed with pHW10 by electroporation.

Construction of plasmid pHW10

The NP production plasmid pHW10 contains the TV BGC xtvAB from X. indica DSM 17382 [33,52]. For its construction yeast homologous recombination (ExRec) cloning was used [53]. Therefore, the shuttle vector pCX2 (genotype: 2μ ori, pBR322 ori, G418^R, Kan^R, pBAD promoter [54]), was linearized by SacI. Next, the TV BGC was amplified by PCR using gDNA from X. indica using the oligonucleotides HW p037 for and HW p038 rev (5′-GTTTCTCCATACCCGTTTTTTTGGGCTAACAGGAGGAATTCCATGATCACAAAACATATCGAGCA-3′, 5′-GTCAACAGCTCCTGCAGGCGCGCCGAGCTCGAATTGCCATTTACTTATATTCCGGTTCATATTTTTT-3′, respectively); letters in italic indicate homologous regions of insert to the pCX2 shuttle vector. Subsequent transformation of yeast cells with linearized pCX2 and the X. indica TV BGC PCR product, isolation of pHW10 and transformation of E. coli DH10B entD::mtaA was performed as described above.

Expression of the TV BGC

For the heterologous expression E. coli DH10B entD::mtaA pHW10 and an E. coli transformant carrying the empty vector pCX2 as a negative control were used. Strains were grown overnight in LB-media containing the appropriate selection marker. These cultures were used for inoculation of 50 mL cultures to an OD₆₀₀ of 0.1 which contained 2% Amberlite^™ XAD-16 (Sigma Aldrich), an appropriate selection marker and 1 mM 3-hydroxy anthranilic acid. Gene expression was induced by the addition of 0.2% (v/v) L-arabinose at the time of inoculation. Incubation was carried out for 72 h at 30°C.

Precursor directed biosynthesis of X. eapokensis

X. eapokensis was grown in liquid SF-900 II SFM (Thermo Fisher Scientific) in presence of 2% Amberlite^™ XAD-16 (Sigmal Aldrich) or SF-900 supplemented with 1 mM of 2-amino-3-chlorobenzoic acid, 2-amino-5-chlorobenzoic acid, 2-amino-3-methylbenzoic acid, 2-amino-5-methylbenzoic acid, 2-amino-3-methoxybenzoic acid, 2-amino-5-methoxybenzoic acid, anthranilic acid, 3-hydroxy anthranilic acid, 3-methyl proline, 3-benzyl proline, or 4-hydroxy proline, pipecolic acid, and 2 mM of 5-fluoro indole, 5-phenyl indole, or 5-methyl indole and 3 mM of 7-azaindole (all chemicals were purchased from Sigma Aldrich). The cultures were cultivated at 30°C for three days with a starting OD₆₀₀ of 0.1 and cultures were extracted as described below.

Mutasynthesis

For mutasynthesis experiments E. coli DH10B entD::mtaA pHW10 cultures were grown at 30 °C for three days in presence of 2% Amberlite^™ XAD-16 with a starting OD₆₀₀ of 0.1 and the TV BGC was induced as described above. LB medium was supplemented as described before for the precursor directed biosynthesis of X. eapokensis. Cultures without supplementation of 2-amino benzoic acid analogs were additionally supplemented with 1 mM of 3-hydroxy anthranilic acid. Finally, cultures were harvested and extracted as described below.

Preparation of culture extracts

After cultivation, the Amberlite^™ XAD-16 was harvested and extracted by shaking using 25 mL of n-butanol for 60 min at 30 °C. The organic phase was filtered and evaporated to dryness under reduced pressure. The extract was reconstituted in 1 mL methanol and a 1:10 dilution was used for UPLC-MS analysis.

Ultra performance liquid chromatography high-resolution mass spectrometry (UPLC-HRMS)

UPLC-ESI-HRMS/MS analysis was performed with an UltiMate 3000 system (Thermo Fisher) coupled to an Impact II qTof mass spectrometer (Bruker) with MeCN/0.1% formic acid in H₂O (5:95 → 50:50% over 13 min followed by 50:50 → 95:5 over 2 min, flow rate 0.4 mL min^-1). A 10 mM sodium formate solution served as an internal mass calibrant. The following MS settings were used: (i) source settings: capillary voltage 4500 V, nebulizer gas pressure (nitrogen) 3 bar, ion source temperature 200 °C, dry gas flow of 8 L min^-1; (ii) general scan settings: ion polarity positive, mass range 80 to 550 m/z, spectra rate 3 Hz (MS and MS/MS); (iii) tune parameters: transfer funnel 1 RF 300 Vpp, Funnel 2 RF 300 Vpp, isCID off, hexapole RF 60 Vpp, stepping settings 20–50 keV; (iv) MS/MS settings: 8 precursor ions, threshold 1000 cts. (absolute), activated active exclusion after 3 spectra and 0.5 min release time, active precursor reconsidering factor 4, smart exclusion 2 times.

Network analysis

Raw MS data of extracts from X. eapokensis cultured in SF-900 was exported from DataAnalysis v4.3 (Bruker) in the .mzXML file format. A molecular network was created using the MS cluster online workflow at GNPS (http://gnps.ucsd.edu/ProteoSAFe/static/gnps-splash.jsp). Network analysis parameters were set as follows: parent mass tolerance of 0.03 Da, MS/MS fragment ion tolerance of 0.05 Da. Consensus spectra that contained less than one spectra were discarded. A network was then created where edges were filtered to have a cosine score above 0.6 and more than five matched peaks. Edges between two nodes were kept in the network only if each of the nodes appeared in each other's respective top 7 most similar nodes.

Cytoscape v3.5.1 [55] was used to visually display the data as a network of nodes and edges and organized with the edge weighted force directed layout. Node annotation was manually performed. Dataset is available under MassIVE id: MSV000081778.

Quantification of TV production

A 0.5 mg TV standard was dissolved in 1 mL methanol and dilutions were generated in a range from 1:1000 to 1:10,000 and measured in technical triplicates using UPLC-HR-MS. Signal area counts of EIC m/z 334.1550 [M+H]⁺ were plotted against concentration, where 1:10,000, 1:2000 and 1:1000 resulted in a linear function (R² = 0.998) used for quantification. The calibration curve is shown in S5 Fig. Other TV derivatives were not quantified but are shown according to their ion intensities in the production cultures.

Supporting information

S1 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in LB medium.

(A) Structure of tilivallin (1) chemical structure. (B) Extracted ion chromatogram (EIC) of 1, m/z 334.1550 [M+H]⁺. MS/MS spectrum of natural (C) and synthetic 1 (D). Mass signals are annotated with predicted sum formulas, detection errors and putative molecule fragment structures. Red diamond indicates precursor ion.

https://doi.org/10.1371/journal.pone.0194297.s001

(DOCX)

S2 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in SF-900 medium.

(A) MS/MS spectrum of dehydro-TV (4). (B) MS/MS spectrum of dehydro-dihydroxy TV (5). Mass signals are annotated with predicted sum formulas, detection errors and putative molecule fragment structures. Red diamond indicates precursor ion.

https://doi.org/10.1371/journal.pone.0194297.s002

(DOCX)

S3 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in SF-900 medium.

Shown are MS/MS spectra of (A) 9-chloro-pyrrolobenzodiazepine (6), (B) 7-chloro-pyrrolobenzodiazepine (7), (C) 9-methyl-pyrrolobenzodiazepine (8), (D) 7-methyl-pyrrolobenzodiazepine (9), (E) 9-methoxy-pyrrolobenzodiazepine (10), (F) 1-methyl-9-hydroxy-pyrrolobenzodiazepine (11), (G) 9-hydroxy-5’-fluoro-pyrrolobenzodiazepine (12), (H) 9-hydroxy-5’phenyl-pyrrolobenzodiazepine (13), (I) 9-hydroxy-5’-methyl-pyrrolobenzodiazepine (14), and (J) 9-hydroxy-azaindole-pyrrolobenzodiazepine (15). Mass signals are annotated with predicted sum formulas, detection errors and putative molecule fragment structures. Red diamond indicates precursor ion.

https://doi.org/10.1371/journal.pone.0194297.s003

(DOCX)

S4 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in SF-900 medium.

(A, B) Extracted ion chromatogram (EIC) of TV intermediates 16 and 17 with corresponding fragment mass spectra (MS/MS) (C, D).

https://doi.org/10.1371/journal.pone.0194297.s004

(DOCX)

S5 Fig. Calibration curve used for tilivallin quantification.

Plotted are signal area counts of EIC m/z 334.1550 [M+H]⁺ corresponding to the used dilution series (1:10,000, 1:2,000 and 1:1,000 dilution of a 0.5 mg/mL stock soltion). Each data point represents the average area count of a triplicate measurement (SD_1:10,000 = 653 counts, SD_1:2,000 = 316 counts, SD_1:1,000 = 292 counts). Graphical error indicators are below display limit. Regression equation and coefficient of determination are given in the diagram.

https://doi.org/10.1371/journal.pone.0194297.s005

(DOCX)

S1 Table. Bacterial strains used and analyzed in this work.

https://doi.org/10.1371/journal.pone.0194297.s006

(DOCX)

S2 Table. Homology of proteins involved in tilivallin biosynthesis based on BLAST analysis of corresponding protein queries.

“*” indicates no NCBI accession number available. “-”indicates no homolog was detected by pBLAST search.

https://doi.org/10.1371/journal.pone.0194297.s007

(DOCX)

S3 Table. Overview of building blocks for the production of TV derivatives in X. eapokensis precursor directed biosynthesis and E. coli DH10B entD::mtaA pHW10 mutasynthesis experiments.

https://doi.org/10.1371/journal.pone.0194297.s008

(DOCX)

Acknowledgments

This work was supported by an ERC starting grant (grant agreement number 311477). The authors are grateful to the Deutsche Forschungsgemeinschaft for funding of the Impact II qTof mass spectrometer (INST 161/810-1) and Rolf Müller for providing a tilivalline standard.

References

1. Chaston JM, Suen G, Tucker SL, Andersen AW, Bhasin A, Bode E, et al. The entomopathogenic bacterial endosymbionts Xenorhabdus and Photorhabdus: convergent lifestyles from divergent genomes. Badger JH, editor. PLoS ONE. Public Library of Science; 2011;6: e27909. pmid:22125637
- View Article
- PubMed/NCBI
- Google Scholar
2. Herbert EE, Goodrich-Blair H. Friend and foe: the two faces of Xenorhabdus nematophila. Nat Rev Microbiol. 2007;5: 634–646. pmid:17618298
- View Article
- PubMed/NCBI
- Google Scholar
3. Forst S, Dowds B, Boemare N, Stackebrandt E. Xenorhabdus and Photorhabdus spp.: Bugs that kill bugs. Annual Review of Microbiology. 1997;51: 47–72. pmid:9343343
- View Article
- PubMed/NCBI
- Google Scholar
4. Bozhüyük KAJ, Zhou Q, Engel Y, Heinrich A, Pérez A, Bode HB. Natural Products from Photorhabdus and Other Entomopathogenic Bacteria. Curr Top Microbiol Immunol. Cham: Springer International Publishing; 2017;402: 55–79. pmid:28091935
- View Article
- PubMed/NCBI
- Google Scholar
5. Challinor VL, Bode HB. Bioactive natural products from novel microbial sources. Wright GD, editor. Ann NY Acad Sci. 2015;1354: 82–97. pmid:26509922
- View Article
- PubMed/NCBI
- Google Scholar
6. Richards GR, Goodrich-Blair H. Examination of Xenorhabdus nematophila Lipases in Pathogenic and Mutualistic Host Interactions Reveals a Role for xlpA in Nematode Progeny Production. Appl Environ Microbiol. 2009;76: 221–229. pmid:19880652
- View Article
- PubMed/NCBI
- Google Scholar
7. Goodrich-Blair H, Clarke DJ. Mutualism and pathogenesis in Xenorhabdus and Photorhabdus: two roads to the same destination. Mol Microbiol. 2007;64: 260–268. pmid:17493120
- View Article
- PubMed/NCBI
- Google Scholar
8. Weber T, Blin K, Duddela S, Krug D, Kim HU, Bruccoleri R, et al. antiSMASH 3.0-a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. Oxford University Press; 2015;43: W237–43. pmid:25948579
- View Article
- PubMed/NCBI
- Google Scholar
9. Marahiel MA. Working outside the protein-synthesis rules: insights into non-ribosomal peptide synthesis. J Pept Sci. John Wiley & Sons, Ltd; 2009;15: 799–807. pmid:19827002
- View Article
- PubMed/NCBI
- Google Scholar
10. Wang M, Carver JJ, Phelan VV, Sanchez LM, Garg N, Peng Y, et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat Biotechnol. Nature Research; 2016;34: 828–837. pmid:27504778
- View Article
- PubMed/NCBI
- Google Scholar
11. Duncan KR, Crüsemann M, Lechner A, Sarkar A, Li J, Ziemert N, et al. Molecular Networking and Pattern-Based Genome Mining Improves Discovery of Biosynthetic Gene Clusters and their Products from Salinispora Species. Cell Chem Biol. Elsevier Ltd; 2015;22: 460–471. pmid:25865308
- View Article
- PubMed/NCBI
- Google Scholar
12. Hurley LH. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. J Antibiot. 1977;30: 349–370. pmid:328469
- View Article
- PubMed/NCBI
- Google Scholar
13. Gerratana B. Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines. Medicinal Research Reviews. 2012;32: 254–293. pmid:20544978
- View Article
- PubMed/NCBI
- Google Scholar
14. Brazhnikova MG, Mesentev AS, Konstantinova NV. Sibiromycin—Isolation and Characterization. J Antibiot. 1972;25: 668–673. pmid:4647835
- View Article
- PubMed/NCBI
- Google Scholar
15. Li W, Khullar A, Chou S, Sacramo A, Gerratana B. Biosynthesis of sibiromycin, a potent antitumor antibiotic. Appl Environ Microbiol. American Society for Microbiology; 2009;75: 2869–2878. pmid:19270142
- View Article
- PubMed/NCBI
- Google Scholar
16. Tendler MD. ‘Refuin’: a Non-cytotoxic Carcinostatic Compound proliferated by a Thermophilic Actinomycete. Nature. 1963;199: 501–501.
- View Article
- Google Scholar
17. Leimgruber W, Stefanović V, Schenker F, KARR A, BERGER J. Isolation and Characterization of Anthramycin a New Antitumor Antibiotic. J Am Chem Soc. 1965;87: 5791–5793. pmid:5845427
- View Article
- PubMed/NCBI
- Google Scholar
18. Hu Y, Phelan V, Ntai I, Farnet CM, Zazopoulos E, Bachmann BO. Benzodiazepine Biosynthesis in Streptomyces refuineus. Cell Chem Biol. 2007;14: 691–701. pmid:17584616
- View Article
- PubMed/NCBI
- Google Scholar
19. Tozuka Z, Takaya T. Studies on tomaymycin. I. J Antibiot. JAPAN ANTIBIOTICS RESEARCH ASSOCIATION; 1983;36: 142–146.
- View Article
- Google Scholar
20. Arima K, Kosaka M, Tamura G, Imanaka H, Sakai H. Studies on tomaymycin, a new antibiotic. I. Isolation and properties of tomaymycin. J Antibiot. 1972;25: 437–444. pmid:4648485
- View Article
- PubMed/NCBI
- Google Scholar
21. Tesmar von A, Hoffmann M, Pippel J, Fayad AA, Dausend-Werner S, Bauer A, et al. Total Biosynthesis of the Pyrrolo[4,2]benzodiazepine Scaffold Tomaymycin on an In Vitro Reconstituted NRPS System. Cell Chem Biol. 2017. pmid:28890318
- View Article
- PubMed/NCBI
- Google Scholar
22. Mohr N, Budzikiewicz H, Korth H, Pulverer G. Bakterieninhaltstoffe, X. 5-Hydroxydesoxyvasicinon, ein Pyrrolochinazolonderivat aus Klebsiella. Liebigs Ann Chem. WILEY-VCH Verlag; 1981;1981: 1515–1518.
- View Article
- Google Scholar
23. Mohr N, Budzikiewicz H. Tilivalline, a new pyrrolo[2, 1-c][1,4] benzodiazepine metabolite from klebsiella. Tetrahedron. 1982;38: 147–152.
- View Article
- Google Scholar
24. Tesmar von A, Hoffmann M, Abou Fayad A, Hüttel S, Schmitt V, Herrmann J, et al. Biosynthesis of the Klebsiella oxytoca pathogenicity factor tilivallin: Heterologous expression, in vitro biosynthesis and inhibitor development. ACS Chem Biol. 2018;: acschembio.7b00990–30. pmid:29389112
- View Article
- PubMed/NCBI
- Google Scholar
25. Chow J, Tang H, Mazmanian SK. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Current Opinion in Immunology. 2011;23: 473–480. pmid:21856139
- View Article
- PubMed/NCBI
- Google Scholar
26. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9: 313–323. pmid:19343057
- View Article
- PubMed/NCBI
- Google Scholar
27. Zollner-Schwetz I, Herzog KAT, Feierl G, Leitner E, Schneditz G, Sprenger H, et al. The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases. Dig Dis Sci. Springer US; 2015;60: 3393–3398. pmid:26091802
- View Article
- PubMed/NCBI
- Google Scholar
28. Schneditz G, Rentner J, Roier S, Pletz J, Herzog KAT, Bücker R, et al. Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis. Proc Natl Acad Sci USA. National Acad Sciences; 2014;111: 13181–13186. pmid:25157164
- View Article
- PubMed/NCBI
- Google Scholar
29. Darby A, Lertpiriyapong K, Sarkar U, Seneviratne U, Park DS, Gamazon ER, et al. Cytotoxic and Pathogenic Properties of Klebsiella oxytoca Isolated from Laboratory Animals. Bereswill S, editor. PLoS ONE. Public Library of Science; 2014;9: e100542–14. pmid:25057966
- View Article
- PubMed/NCBI
- Google Scholar
30. Beaugerie L, Metz M, Barbut F, Bellaiche G, Bouhnik Y, Raskine L, et al. Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis. Clin Gastroenterol Hepatol. 2003;1: 370–376. pmid:15017655
- View Article
- PubMed/NCBI
- Google Scholar
31. Högenauer C, Langner C, Beubler E, Lippe IT, Schicho R, Gorkiewicz G, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med. 2006;355: 2418–2426. pmid:17151365
- View Article
- PubMed/NCBI
- Google Scholar
32. Kaempfer P, Tobias NJ, Ke Long P, Bode HB, Glaeser SP. Xenorhabdus thuongxuanensis sp nov and Xenorhabdus eapokensis sp nov., isolated from Steinernema species. Int J Syst Evol Microbiol. 2017;67: 1107–1114. pmid:28056225
- View Article
- PubMed/NCBI
- Google Scholar
33. Tobias NJ, Wolff H, Djahanschiri B, Grundmann F, Kronenwerth M, Shi Y-M, et al. Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus. Nat Microbiol. 2017;2: 1676–1685. pmid:28993611
- View Article
- PubMed/NCBI
- Google Scholar
34. Tse H, Yang D, Sze K-H, Chu IK, Kao RYT, Lee K-C, et al. A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis. J Biol Chem. American Society for Biochemistry and Molecular Biology; 2017;292: jbc.M117.791558–35. pmid:28972161
- View Article
- PubMed/NCBI
- Google Scholar
35. Franza T, Expert D. The virulence-associated chrysobactin iron uptake system of Erwinia chrysanthemi 3937 involves an operon encoding transport and biosynthetic functions. J Bacteriol. American Society for Microbiology (ASM); 1991;173: 6874–6881.
- View Article
- Google Scholar
36. Dornisch E, Pletz J, Glabonjat RA, Martin F, Lembacher-Fadum C, Neger M, et al. Biosynthesis of the enterotoxic pyrrolobenzodiazepine natural product tilivalline. Angew Chem Int Ed. 2017;: 1–6. pmid:28977734
- View Article
- PubMed/NCBI
- Google Scholar
37. Yonemoto IT, Li W, Khullar A, Reixach N, Gerratana B. Mutasynthesis of a potent anticancer sibiromycin analogue. ACS Chem Biol. 2012;7: 973–977. pmid:22390171
- View Article
- PubMed/NCBI
- Google Scholar
38. Li W, Chou S, Khullar A, Gerratana B. Cloning and characterization of the biosynthetic gene cluster for tomaymycin, an SJG-136 monomeric analog. Appl Environ Microbiol. American Society for Microbiology; 2009;75: 2958–2963. pmid:19270147
- View Article
- PubMed/NCBI
- Google Scholar
39. Ling M, Allen SW, Wood JM. Sequence analysis identifies the proline dehydrogenase and delta 1-pyrroline-5-carboxylate dehydrogenase domains of the multifunctional Escherichia coli PutA protein. J Mol Biol. 1994;243: 950–956. pmid:7966312
- View Article
- PubMed/NCBI
- Google Scholar
40. Satomura T, Kawakami R, Sakuraba H, Ohshima T. Dye-linked D-proline dehydrogenase from hyperthermophilic archaeon Pyrobaculum islandicum is a novel FAD-dependent amino acid dehydrogenase. J Biol Chem. American Society for Biochemistry and Molecular Biology; 2002;277: 12861–12867. pmid:11823469
- View Article
- PubMed/NCBI
- Google Scholar
41. Zhang X, Kumar R, Vetting MW, Zhao S, Jacobson MP, Almo SC, et al. A Unique cis-3-Hydroxy- l-proline Dehydratase in the Enolase Superfamily. J Am Chem Soc. 2015;137: 1388–1391. pmid:25608448
- View Article
- PubMed/NCBI
- Google Scholar
42. Haslinger K, Peschke M, Brieke C, Maximowitsch E, Cryle MJ. X-domain of peptide synthetases recruits oxygenases crucial for glycopeptide biosynthesis. Nature. Nature Publishing Group; 2015;521: 105–109. pmid:25686610
- View Article
- PubMed/NCBI
- Google Scholar
43. Jackson PJM, James CH, Jenkins TC, Rahman KM, Thurston DE. Computational Studies Support the Role of the C7-Sibirosamine Sugar of the Pyrrolobenzodiazepine (PBD) Sibiromycin in Transcription Factor Inhibition. ACS Chem Biol. 2014;9: 2432–2440. pmid:25111266
- View Article
- PubMed/NCBI
- Google Scholar
44. Nagasaka T, Koseki Y. Stereoselective synthesis of tilivalline. J Org Chem. 1998;63: 6797–6801. pmid:11672297
- View Article
- PubMed/NCBI
- Google Scholar
45. Tercel M, Stribbling SM, Sheppard H, Siim BG, Wu K, Pullen SM, et al. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores. J Med Chem. 2003;46: 2132–2151. pmid:12747786
- View Article
- PubMed/NCBI
- Google Scholar
46. Sutherland MSK, Walter RB, Jeffrey SC, Burke PJ, Yu C, Kostner H, et al. SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. Blood. American Society of Hematology; 2013;122: 1455–1463. pmid:23770776
- View Article
- PubMed/NCBI
- Google Scholar
47. Kopka ML, Goodsell DS, Baikalov I, Grzeskowiak K, Cascio D, Dickerson RE. Crystal-Structure of a Covalent Dna Drug Adduct—Anthramycin Bound to C-C-a-a-C-G-T-T-G-G and a Molecular Explanation of Specificity. Biochemistry. 1994;33: 13593–13610. pmid:7947769
- View Article
- PubMed/NCBI
- Google Scholar
48. Shi Y-M, Bode HB. Chemical language and warfare of bacterial natural products in bacteria–nematode–insect interactions. Nat Prod Rep. Royal Society of Chemistry; 2018;00: 1–27. pmid:29359226
- View Article
- PubMed/NCBI
- Google Scholar
49. Bode HB. Entomopathogenic bacteria as a source of secondary metabolites. Curr Opin Chem Biol. 2009;13: 224–230. pmid:19345136
- View Article
- PubMed/NCBI
- Google Scholar
50. Ciche TA, Ensign JC. For the Insect Pathogen Photorhabdus luminescens, Which End of a Nematode Is Out? Appl Environ Microbiol. 2003;69: 1890–1897. pmid:12676661
- View Article
- PubMed/NCBI
- Google Scholar
51. Gietz RD, Schiestl RH. Frozen competent yeast cells that can be transformed with high efficiency using the LiAc/SS carrier DNA/PEG method. Nat Protoc. 2007;2: 1–4. pmid:17401330
- View Article
- PubMed/NCBI
- Google Scholar
52. Somvanshi VS, Lang E, Ganguly S, Swiderski J, Saxena AK, Stackebrandt E. A novel species of Xenorhabdus, family Enterobacteriaceae: Xenorhabdus indica sp. nov., symbiotically associated with entomopathogenic nematode Steinernema thermophilum Ganguly and Singh, 2000. Systematic and Applied Microbiology. 2006;29: 519–525. pmid:16459045
- View Article
- PubMed/NCBI
- Google Scholar
53. Tsunematsu Y, Ishiuchi K, Hotta K, Watanabe K. Yeast-based genome mining, production and mechanistic studies of the biosynthesis of fungal polyketide and peptide natural products. Nat Prod Rep. Royal Society of Chemistry; 2013;30: 1139–1149. pmid:23824111
- View Article
- PubMed/NCBI
- Google Scholar
54. Schimming O, Challinor VL, Tobias NJ, Adihou H, Grün P, Pöschel L, et al. Structure, Biosynthesis, and Occurrence of Bacterial Pyrrolizidine Alkaloids. Angew Chem. 2015;127: 12893–12896.
- View Article
- Google Scholar
55. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13: 2498–2504. pmid:14597658
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Chaston JM, Suen G, Tucker SL, Andersen AW, Bhasin A, Bode E, et al. The entomopathogenic bacterial endosymbionts Xenorhabdus and Photorhabdus: convergent lifestyles from divergent genomes. Badger JH, editor. PLoS ONE. Public Library of Science; 2011;6: e27909. pmid:22125637
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Herbert EE, Goodrich-Blair H. Friend and foe: the two faces of Xenorhabdus nematophila. Nat Rev Microbiol. 2007;5: 634–646. pmid:17618298
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Forst S, Dowds B, Boemare N, Stackebrandt E. Xenorhabdus and Photorhabdus spp.: Bugs that kill bugs. Annual Review of Microbiology. 1997;51: 47–72. pmid:9343343
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Bozhüyük KAJ, Zhou Q, Engel Y, Heinrich A, Pérez A, Bode HB. Natural Products from Photorhabdus and Other Entomopathogenic Bacteria. Curr Top Microbiol Immunol. Cham: Springer International Publishing; 2017;402: 55–79. pmid:28091935
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Challinor VL, Bode HB. Bioactive natural products from novel microbial sources. Wright GD, editor. Ann NY Acad Sci. 2015;1354: 82–97. pmid:26509922
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Richards GR, Goodrich-Blair H. Examination of Xenorhabdus nematophila Lipases in Pathogenic and Mutualistic Host Interactions Reveals a Role for xlpA in Nematode Progeny Production. Appl Environ Microbiol. 2009;76: 221–229. pmid:19880652
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Goodrich-Blair H, Clarke DJ. Mutualism and pathogenesis in Xenorhabdus and Photorhabdus: two roads to the same destination. Mol Microbiol. 2007;64: 260–268. pmid:17493120
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Weber T, Blin K, Duddela S, Krug D, Kim HU, Bruccoleri R, et al. antiSMASH 3.0-a comprehensive resource for the genome mining of biosynthetic gene clusters. Nucleic Acids Res. Oxford University Press; 2015;43: W237–43. pmid:25948579
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Marahiel MA. Working outside the protein-synthesis rules: insights into non-ribosomal peptide synthesis. J Pept Sci. John Wiley & Sons, Ltd; 2009;15: 799–807. pmid:19827002
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Wang M, Carver JJ, Phelan VV, Sanchez LM, Garg N, Peng Y, et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat Biotechnol. Nature Research; 2016;34: 828–837. pmid:27504778
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Duncan KR, Crüsemann M, Lechner A, Sarkar A, Li J, Ziemert N, et al. Molecular Networking and Pattern-Based Genome Mining Improves Discovery of Biosynthetic Gene Clusters and their Products from Salinispora Species. Cell Chem Biol. Elsevier Ltd; 2015;22: 460–471. pmid:25865308
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Hurley LH. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. J Antibiot. 1977;30: 349–370. pmid:328469
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Gerratana B. Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines. Medicinal Research Reviews. 2012;32: 254–293. pmid:20544978
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Brazhnikova MG, Mesentev AS, Konstantinova NV. Sibiromycin—Isolation and Characterization. J Antibiot. 1972;25: 668–673. pmid:4647835
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Li W, Khullar A, Chou S, Sacramo A, Gerratana B. Biosynthesis of sibiromycin, a potent antitumor antibiotic. Appl Environ Microbiol. American Society for Microbiology; 2009;75: 2869–2878. pmid:19270142
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Tendler MD. ‘Refuin’: a Non-cytotoxic Carcinostatic Compound proliferated by a Thermophilic Actinomycete. Nature. 1963;199: 501–501.
View Article
Google Scholar

[62] View Article

[63] Google Scholar

[ref17] 17. Leimgruber W, Stefanović V, Schenker F, KARR A, BERGER J. Isolation and Characterization of Anthramycin a New Antitumor Antibiotic. J Am Chem Soc. 1965;87: 5791–5793. pmid:5845427
View Article
PubMed/NCBI
Google Scholar

[65] View Article

[66] PubMed/NCBI

[67] Google Scholar

[ref18] 18. Hu Y, Phelan V, Ntai I, Farnet CM, Zazopoulos E, Bachmann BO. Benzodiazepine Biosynthesis in Streptomyces refuineus. Cell Chem Biol. 2007;14: 691–701. pmid:17584616
View Article
PubMed/NCBI
Google Scholar

[69] View Article

[70] PubMed/NCBI

[71] Google Scholar

[ref19] 19. Tozuka Z, Takaya T. Studies on tomaymycin. I. J Antibiot. JAPAN ANTIBIOTICS RESEARCH ASSOCIATION; 1983;36: 142–146.
View Article
Google Scholar

[73] View Article

[74] Google Scholar

[ref20] 20. Arima K, Kosaka M, Tamura G, Imanaka H, Sakai H. Studies on tomaymycin, a new antibiotic. I. Isolation and properties of tomaymycin. J Antibiot. 1972;25: 437–444. pmid:4648485
View Article
PubMed/NCBI
Google Scholar

[76] View Article

[77] PubMed/NCBI

[78] Google Scholar

[ref21] 21. Tesmar von A, Hoffmann M, Pippel J, Fayad AA, Dausend-Werner S, Bauer A, et al. Total Biosynthesis of the Pyrrolo[4,2]benzodiazepine Scaffold Tomaymycin on an In Vitro Reconstituted NRPS System. Cell Chem Biol. 2017. pmid:28890318
View Article
PubMed/NCBI
Google Scholar

[80] View Article

[81] PubMed/NCBI

[82] Google Scholar

[ref22] 22. Mohr N, Budzikiewicz H, Korth H, Pulverer G. Bakterieninhaltstoffe, X. 5-Hydroxydesoxyvasicinon, ein Pyrrolochinazolonderivat aus Klebsiella. Liebigs Ann Chem. WILEY-VCH Verlag; 1981;1981: 1515–1518.
View Article
Google Scholar

[84] View Article

[85] Google Scholar

[ref23] 23. Mohr N, Budzikiewicz H. Tilivalline, a new pyrrolo[2, 1-c][1,4] benzodiazepine metabolite from klebsiella. Tetrahedron. 1982;38: 147–152.
View Article
Google Scholar

[87] View Article

[88] Google Scholar

[ref24] 24. Tesmar von A, Hoffmann M, Abou Fayad A, Hüttel S, Schmitt V, Herrmann J, et al. Biosynthesis of the Klebsiella oxytoca pathogenicity factor tilivallin: Heterologous expression, in vitro biosynthesis and inhibitor development. ACS Chem Biol. 2018;: acschembio.7b00990–30. pmid:29389112
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref25] 25. Chow J, Tang H, Mazmanian SK. Pathobionts of the gastrointestinal microbiota and inflammatory disease. Current Opinion in Immunology. 2011;23: 473–480. pmid:21856139
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref26] 26. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9: 313–323. pmid:19343057
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref27] 27. Zollner-Schwetz I, Herzog KAT, Feierl G, Leitner E, Schneditz G, Sprenger H, et al. The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases. Dig Dis Sci. Springer US; 2015;60: 3393–3398. pmid:26091802
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref28] 28. Schneditz G, Rentner J, Roier S, Pletz J, Herzog KAT, Bücker R, et al. Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis. Proc Natl Acad Sci USA. National Acad Sciences; 2014;111: 13181–13186. pmid:25157164
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref29] 29. Darby A, Lertpiriyapong K, Sarkar U, Seneviratne U, Park DS, Gamazon ER, et al. Cytotoxic and Pathogenic Properties of Klebsiella oxytoca Isolated from Laboratory Animals. Bereswill S, editor. PLoS ONE. Public Library of Science; 2014;9: e100542–14. pmid:25057966
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref30] 30. Beaugerie L, Metz M, Barbut F, Bellaiche G, Bouhnik Y, Raskine L, et al. Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis. Clin Gastroenterol Hepatol. 2003;1: 370–376. pmid:15017655
View Article
PubMed/NCBI
Google Scholar

[114] View Article

[115] PubMed/NCBI

[116] Google Scholar

[ref31] 31. Högenauer C, Langner C, Beubler E, Lippe IT, Schicho R, Gorkiewicz G, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med. 2006;355: 2418–2426. pmid:17151365
View Article
PubMed/NCBI
Google Scholar

[118] View Article

[119] PubMed/NCBI

[120] Google Scholar

[ref32] 32. Kaempfer P, Tobias NJ, Ke Long P, Bode HB, Glaeser SP. Xenorhabdus thuongxuanensis sp nov and Xenorhabdus eapokensis sp nov., isolated from Steinernema species. Int J Syst Evol Microbiol. 2017;67: 1107–1114. pmid:28056225
View Article
PubMed/NCBI
Google Scholar

[122] View Article

[123] PubMed/NCBI

[124] Google Scholar

[ref33] 33. Tobias NJ, Wolff H, Djahanschiri B, Grundmann F, Kronenwerth M, Shi Y-M, et al. Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus. Nat Microbiol. 2017;2: 1676–1685. pmid:28993611
View Article
PubMed/NCBI
Google Scholar

[126] View Article

[127] PubMed/NCBI

[128] Google Scholar

[ref34] 34. Tse H, Yang D, Sze K-H, Chu IK, Kao RYT, Lee K-C, et al. A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis. J Biol Chem. American Society for Biochemistry and Molecular Biology; 2017;292: jbc.M117.791558–35. pmid:28972161
View Article
PubMed/NCBI
Google Scholar

[130] View Article

[131] PubMed/NCBI

[132] Google Scholar

[ref35] 35. Franza T, Expert D. The virulence-associated chrysobactin iron uptake system of Erwinia chrysanthemi 3937 involves an operon encoding transport and biosynthetic functions. J Bacteriol. American Society for Microbiology (ASM); 1991;173: 6874–6881.
View Article
Google Scholar

[134] View Article

[135] Google Scholar

[ref36] 36. Dornisch E, Pletz J, Glabonjat RA, Martin F, Lembacher-Fadum C, Neger M, et al. Biosynthesis of the enterotoxic pyrrolobenzodiazepine natural product tilivalline. Angew Chem Int Ed. 2017;: 1–6. pmid:28977734
View Article
PubMed/NCBI
Google Scholar

[137] View Article

[138] PubMed/NCBI

[139] Google Scholar

[ref37] 37. Yonemoto IT, Li W, Khullar A, Reixach N, Gerratana B. Mutasynthesis of a potent anticancer sibiromycin analogue. ACS Chem Biol. 2012;7: 973–977. pmid:22390171
View Article
PubMed/NCBI
Google Scholar

[141] View Article

[142] PubMed/NCBI

[143] Google Scholar

[ref38] 38. Li W, Chou S, Khullar A, Gerratana B. Cloning and characterization of the biosynthetic gene cluster for tomaymycin, an SJG-136 monomeric analog. Appl Environ Microbiol. American Society for Microbiology; 2009;75: 2958–2963. pmid:19270147
View Article
PubMed/NCBI
Google Scholar

[145] View Article

[146] PubMed/NCBI

[147] Google Scholar

[ref39] 39. Ling M, Allen SW, Wood JM. Sequence analysis identifies the proline dehydrogenase and delta 1-pyrroline-5-carboxylate dehydrogenase domains of the multifunctional Escherichia coli PutA protein. J Mol Biol. 1994;243: 950–956. pmid:7966312
View Article
PubMed/NCBI
Google Scholar

[149] View Article

[150] PubMed/NCBI

[151] Google Scholar

[ref40] 40. Satomura T, Kawakami R, Sakuraba H, Ohshima T. Dye-linked D-proline dehydrogenase from hyperthermophilic archaeon Pyrobaculum islandicum is a novel FAD-dependent amino acid dehydrogenase. J Biol Chem. American Society for Biochemistry and Molecular Biology; 2002;277: 12861–12867. pmid:11823469
View Article
PubMed/NCBI
Google Scholar

[153] View Article

[154] PubMed/NCBI

[155] Google Scholar

[ref41] 41. Zhang X, Kumar R, Vetting MW, Zhao S, Jacobson MP, Almo SC, et al. A Unique cis-3-Hydroxy- l-proline Dehydratase in the Enolase Superfamily. J Am Chem Soc. 2015;137: 1388–1391. pmid:25608448
View Article
PubMed/NCBI
Google Scholar

[157] View Article

[158] PubMed/NCBI

[159] Google Scholar

[ref42] 42. Haslinger K, Peschke M, Brieke C, Maximowitsch E, Cryle MJ. X-domain of peptide synthetases recruits oxygenases crucial for glycopeptide biosynthesis. Nature. Nature Publishing Group; 2015;521: 105–109. pmid:25686610
View Article
PubMed/NCBI
Google Scholar

[161] View Article

[162] PubMed/NCBI

[163] Google Scholar

[ref43] 43. Jackson PJM, James CH, Jenkins TC, Rahman KM, Thurston DE. Computational Studies Support the Role of the C7-Sibirosamine Sugar of the Pyrrolobenzodiazepine (PBD) Sibiromycin in Transcription Factor Inhibition. ACS Chem Biol. 2014;9: 2432–2440. pmid:25111266
View Article
PubMed/NCBI
Google Scholar

[165] View Article

[166] PubMed/NCBI

[167] Google Scholar

[ref44] 44. Nagasaka T, Koseki Y. Stereoselective synthesis of tilivalline. J Org Chem. 1998;63: 6797–6801. pmid:11672297
View Article
PubMed/NCBI
Google Scholar

[169] View Article

[170] PubMed/NCBI

[171] Google Scholar

[ref45] 45. Tercel M, Stribbling SM, Sheppard H, Siim BG, Wu K, Pullen SM, et al. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores. J Med Chem. 2003;46: 2132–2151. pmid:12747786
View Article
PubMed/NCBI
Google Scholar

[173] View Article

[174] PubMed/NCBI

[175] Google Scholar

[ref46] 46. Sutherland MSK, Walter RB, Jeffrey SC, Burke PJ, Yu C, Kostner H, et al. SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. Blood. American Society of Hematology; 2013;122: 1455–1463. pmid:23770776
View Article
PubMed/NCBI
Google Scholar

[177] View Article

[178] PubMed/NCBI

[179] Google Scholar

[ref47] 47. Kopka ML, Goodsell DS, Baikalov I, Grzeskowiak K, Cascio D, Dickerson RE. Crystal-Structure of a Covalent Dna Drug Adduct—Anthramycin Bound to C-C-a-a-C-G-T-T-G-G and a Molecular Explanation of Specificity. Biochemistry. 1994;33: 13593–13610. pmid:7947769
View Article
PubMed/NCBI
Google Scholar

[181] View Article

[182] PubMed/NCBI

[183] Google Scholar

[ref48] 48. Shi Y-M, Bode HB. Chemical language and warfare of bacterial natural products in bacteria–nematode–insect interactions. Nat Prod Rep. Royal Society of Chemistry; 2018;00: 1–27. pmid:29359226
View Article
PubMed/NCBI
Google Scholar

[185] View Article

[186] PubMed/NCBI

[187] Google Scholar

[ref49] 49. Bode HB. Entomopathogenic bacteria as a source of secondary metabolites. Curr Opin Chem Biol. 2009;13: 224–230. pmid:19345136
View Article
PubMed/NCBI
Google Scholar

[189] View Article

[190] PubMed/NCBI

[191] Google Scholar

[ref50] 50. Ciche TA, Ensign JC. For the Insect Pathogen Photorhabdus luminescens, Which End of a Nematode Is Out? Appl Environ Microbiol. 2003;69: 1890–1897. pmid:12676661
View Article
PubMed/NCBI
Google Scholar

[193] View Article

[194] PubMed/NCBI

[195] Google Scholar

[ref51] 51. Gietz RD, Schiestl RH. Frozen competent yeast cells that can be transformed with high efficiency using the LiAc/SS carrier DNA/PEG method. Nat Protoc. 2007;2: 1–4. pmid:17401330
View Article
PubMed/NCBI
Google Scholar

[197] View Article

[198] PubMed/NCBI

[199] Google Scholar

[ref52] 52. Somvanshi VS, Lang E, Ganguly S, Swiderski J, Saxena AK, Stackebrandt E. A novel species of Xenorhabdus, family Enterobacteriaceae: Xenorhabdus indica sp. nov., symbiotically associated with entomopathogenic nematode Steinernema thermophilum Ganguly and Singh, 2000. Systematic and Applied Microbiology. 2006;29: 519–525. pmid:16459045
View Article
PubMed/NCBI
Google Scholar

[201] View Article

[202] PubMed/NCBI

[203] Google Scholar

[ref53] 53. Tsunematsu Y, Ishiuchi K, Hotta K, Watanabe K. Yeast-based genome mining, production and mechanistic studies of the biosynthesis of fungal polyketide and peptide natural products. Nat Prod Rep. Royal Society of Chemistry; 2013;30: 1139–1149. pmid:23824111
View Article
PubMed/NCBI
Google Scholar

[205] View Article

[206] PubMed/NCBI

[207] Google Scholar

[ref54] 54. Schimming O, Challinor VL, Tobias NJ, Adihou H, Grün P, Pöschel L, et al. Structure, Biosynthesis, and Occurrence of Bacterial Pyrrolizidine Alkaloids. Angew Chem. 2015;127: 12893–12896.
View Article
Google Scholar

[209] View Article

[210] Google Scholar

[ref55] 55. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13: 2498–2504. pmid:14597658
View Article
PubMed/NCBI
Google Scholar

[212] View Article

[213] PubMed/NCBI

[214] Google Scholar

Figures

Abstract

Introduction

Results

Tilivalline gene cluster analysis

Production of tilivalline and natural analogs in X. eapokensis

X. eapokensis precursor directed biosynthesis and enhanced TV production

Heterologous expression of XtvAB from X. indica

E. coli TV production and mutasynthesis

Discussion

Material and methods

Identification of the TV BGC in Xenorhabdus

Cultivation of microorganisms

Molecular biological methods

Construction of plasmid pHW10

Expression of the TV BGC

Precursor directed biosynthesis of X. eapokensis

Mutasynthesis

Preparation of culture extracts

Ultra performance liquid chromatography high-resolution mass spectrometry (UPLC-HRMS)

Network analysis

Quantification of TV production

Supporting information

S1 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in LB medium.

S2 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in SF-900 medium.

S3 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in SF-900 medium.

S4 Fig. UPLC-HRMS/MS analysis of a crude extract of X. eapokensis grown in SF-900 medium.

S5 Fig. Calibration curve used for tilivallin quantification.

S1 Table. Bacterial strains used and analyzed in this work.

S2 Table. Homology of proteins involved in tilivallin biosynthesis based on BLAST analysis of corresponding protein queries.

S3 Table. Overview of building blocks for the production of TV derivatives in X. eapokensis precursor directed biosynthesis and E. coli DH10B entD::mtaA pHW10 mutasynthesis experiments.

Acknowledgments

References